Lowering the TG/HDL-C ratio can prevent type 2 diabetes and type 2 diabetes.

Published Date: 17 Mar 2023

Iran: According to a study published in Diabetology and Metabolic Syndrome, triglycerides are elevated in normoglycemic patients.

Read Full News

Latest News

GLP-1s for Addiction: Are We There Yet?

The same drugs that transformed obesity treatment are now being investigated for substance use disorders, fueling interest in a new approach to addiction treatment.

OTC Continuous Glucose Monitor Adds AI Features

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI coaching and other app-based features.

Analysis-Older Americans Left Out Of Costly GLP-1 Craze Expected to Flock to New Program

Millions more Americans will qualify for obesity medications at just $50 a month under a new Medicare program starting on Wednesday, bringing the highly effective drugs to...

Explainer-Who Qualifies for Medicare's New $50 Weight-loss Drug Program and What Are the Concerns?

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65...

Tirzepatide Weight Loss Greater in Women vs Men, Age No Link

In adults with overweight or obesity using tirzepatide for at least 12 months, women lost more weight, but age was not a predictor.

Pfizer, Innovent GLP-1 Drugs Clear China Insurance Hurdle

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

Todays Updates

Ocular Motor Cranial Neuropathy Tied to Parkinson’s Disease

Ocular motor cranial neuropathy is associated with an increased risk for Parkinson’s disease, a new study shows.

TBI Shows Two-Way Association With Neurologic Conditions

Traumatic brain injury is bidirectionally associated with the incidence of stroke, dementia, epilepsy, and Parkinson’s disease, a retrospective study shows.

Pediatric Cancer in the 2000s: Uneven Survival Gains Seen

A large database study found overall 5- and 10-year improvement in pediatric cancer survival, but some cancers lag others, and demographic factors seem to influence trends.

Rheumatologist Shortage to Hit Nonmetropolitan Areas Hardest

Workforce projections show an uneven distribution of rheumatologists in the US, with notable shortages in nonmetropolitan areas and certain states and districts.

Epcoritamab Shows Promise in Frail Older Adults With LBCL

A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.

NHS Extends RSV Jab to At-Risk Adults Aged 65-74

All adults aged 65-74 with a chronic respiratory condition or a weakened immune system will be offered the RSV vaccine from September, NHS England has confirmed.

Coffee and the Gut: What’s Brewing in the Microbiome?

Emerging evidence suggests coffee influences gut microbiota through bioactive compounds beyond caffeine, with potential effects on digestive and metabolic health.

Todays Updates

Ocular Motor Cranial Neuropathy Tied to Parkinson’s Disease

Ocular motor cranial neuropathy is associated with an increased risk for Parkinson’s disease, a new study shows.

TBI Shows Two-Way Association With Neurologic Conditions

Traumatic brain injury is bidirectionally associated with the incidence of stroke, dementia, epilepsy, and Parkinson’s disease, a retrospective study shows.

Pediatric Cancer in the 2000s: Uneven Survival Gains Seen

A large database study found overall 5- and 10-year improvement in pediatric cancer survival, but some cancers lag others, and demographic factors seem to influence trends.

Rheumatologist Shortage to Hit Nonmetropolitan Areas Hardest

Workforce projections show an uneven distribution of rheumatologists in the US, with notable shortages in nonmetropolitan areas and certain states and districts.

Epcoritamab Shows Promise in Frail Older Adults With LBCL

A phase 2 trial assesses fixed-duration epcoritamab monotherapy as first-line therapy for frail older adults with newly diagnosed anthracycline-ineligible large B-cell lymphoma.

NHS Extends RSV Jab to At-Risk Adults Aged 65-74

All adults aged 65-74 with a chronic respiratory condition or a weakened immune system will be offered the RSV vaccine from September, NHS England has confirmed.

Coffee and the Gut: What’s Brewing in the Microbiome?

Emerging evidence suggests coffee influences gut microbiota through bioactive compounds beyond caffeine, with potential effects on digestive and metabolic health.

Latest News

The same drugs that transformed obesity treatment are now being investigated for substance use disorders, fueling interest in a new approach to addiction treatment.

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI coaching and other app-based features.

Millions more Americans will qualify for obesity medications at just $50 a month under a new Medicare program starting on Wednesday, bringing the highly effective drugs to...

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65...

In adults with overweight or obesity using tirzepatide for at least 12 months, women lost more weight, but age was not a predictor.

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

News All Time

Unapproved Retatrutide Use Challenges Clinicians

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manage patients taking the drug.

Imaging Predicts Therapy Failure in T2-T3 Glottic Cancers

Vertical anterior commissure involvement identified on preoperative imaging predicts poor outcomes in patients undergoing primary chemoradiotherapy for T2-T3 glottic tumours.

QOL After Weight-Loss Surgery Persists Despite Regain

In a prospective study, long-term improvements in QOL after metabolic and bariatric surgery are largely maintained in both patients experiencing weight regain of less than 30% and 30% or more.

Bariatric Surgery Outperforms Diet for Cancer Prevention

Metabolic/bariatric surgery is linked to a lower risk for multiple cancers in patients with severe obesity than dietary counseling, a large analysis shows.

Bone Agents Underused, and Declining, in Prostate Cancer

Many patients with metastatic castration-resistant prostate cancer are not receiving bone-modifying agents, despite guideline endorsement.

Novo's Top US Exec Wants More Insurance Coverage for Weight-loss Drugs

Denmark's Novo Nordisk, the maker of weight-loss drug Wegovy, hopes insurance will cover more U.S. users of the medication and balance direct-to-consumer sales that have...

Two Studies Link GLP-1 Use to Lower Breast Cancer Risk

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

Trump Pricing Policy Will Affect Obesity Drug Launch in Europe

Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of ⁠2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market.

GLP-1 QOL Benefits Greatest for Those With Obesity Plus T2D

Patients with co-occurring obesity and T2D have more favorable QOL outcomes on GLP-1s than those with either condition alone or multiple comorbidities.

China Approval for Eli Lilly GLP-1 Pill to Come as Soon as 2026, Executive Says

Eli Lilly's orforglipron type-2 diabetes and obesity pill could launch in China as soon ⁠as later this year, an executive at the U.S. drugmaker told Reuters, as rival Novo...

Mediterranean Diet May Reduce Postpartum Metabolic Risk

A Mediterranean-based nutritional intervention initiated at 8-12 gestational weeks is associated with a reduced risk for metabolic syndrome 6 years postpartum, a prospective follow-up study finds.

Urogenital Infections Tied to SGLT2 Therapy Discontinuation

Patients with type 2 diabetes who start SGLT2 inhibitors and then develop a urinary or genital tract infection are more likely to discontinue treatment than matched patients without an infection.

Protein Source Key for Weight Loss After Menopause

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

What GLP-1s Are Teaching Us About Compulsive Behavior

As GLP-1 research moves deeper into the brain, scientists are asking whether these drugs can help explain why some urges become so hard to resist.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

Recommended News For You

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

Skinny melanoma incidence is associated with vitamin D deficiency.

How breast tissue density affects your risk of breast cancer

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Recommended Articles For You

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies 

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms 

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Hematopoietic Stem Cell Fitness Biomarkers: Clinical Relevance and Emerging Paradigms 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

2.

Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC

3.

Hereditary cancer has a rare and underreported cause.

4.

New imaging guidelines for head and neck cancers, a step toward practice change

5.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

1.

Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control

2.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

3.

Essential Updates in Hematology in Daily Practice

4.

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management

5.

Importance of Early Detection in Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

3.

Current Scenario of Cancer- The Incidence of Cancer in Men

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

A New Era in Managing Cancer-Associated Thrombosis

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot